Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00249717 · ClinicalTrials.gov registry record · NA

Group-Based Contingency Management for Substance Abuse Treatment - 1

A NA study, sponsored by UConn Health.

Completed
Registry status
NA
Development phase
312
Enrollment target

NCT00249717: Completed NA study, sponsored by UConn Health.

NCT00249717 is a NA study that has completed, run by UConn Health. The registered enrollment target is 312 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00249717, a NA study, has completed, sponsored by UConn Health.

COMPLETED
Registry status
NA
Development phase
312 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the efficacy of prize-based contingency management (CM) when administered exclusively in groups. Substance dependent patients (N=360) at community-based treatment programs are randomly assigned to one of two conditions: (a) standard, non-CM treatment or (b) standard treatment plus prize CM delivered in groups. In the CM condition, patients earn the opportunity to win prizes for attending groups and submitting drug-free biological specimens. Substance use and psychosocial problems are measured at intake, month 1, month 3 (post treatment), and at 6-, 9-, and 12-month follow-up evaluations. We also assess patient characteristics that may be associated with improved outcomes within and across conditions.

Interventions

  • BEHAVIORAL Contingency management

Trial Details

FieldValue
Enrollment Target 312 participants
Start Date 2005-05
Est. Completion 2010-01
Phase NA
UConn Health

178 total trials

What the finished NCT00249717 record still lists

NCT00249717 is an interventional study that assigns participants to a tested intervention. The registered 312 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower).

The record links to 0 conditions, and to 1 intervention - of which Contingency management is the first listed.

NCT00249717 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00249717 about?

NCT00249717 is a clinical study titled "Group-Based Contingency Management for Substance Abuse Treatment - 1". The purpose of this study is to evaluate the efficacy of prize-based contingency management (CM) when administered exclusively in groups. Substance dependent patients (N=360) at community-based treatment programs are randomly assigned to one of two conditions: (a) standard, non-CM treatment or (b) s...

What is the current status of trial NCT00249717?

This trial is currently completed. It is a NA study. The enrollment target is 312 participants. The study started on 2005-05. Estimated completion is 2010-01.

What interventions are being tested in trial NCT00249717?

The interventions under investigation include: Contingency management (BEHAVIORAL).

Who is sponsoring clinical trial NCT00249717?

This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00249717's enrollment target sits among peer trials

312 323rd of 2000 higher than 1,678 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04984551 · 312 participants · Phase 2

    Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia

  • NCT04999904 · 312 participants · NA

    A Proprioceptive Training Program Using an Uneven Terrain Treadmill for Patients With Ankle Instability

  • NCT05220332 · 312 participants · NA

    Church-based Intervention to Improve Blood Pressure in African Americans

  • NCT05434234 · 312 participants · Phase 1

    A Study of YL201 in Patients With Advanced Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00249717, the US trial registry maintained by the National Library of Medicine. NCT00249717 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.